Pharmaceuticals
We aim to improve people’s quality of life with our products. To achieve this, we concentrate on the research and development of innovative drugs and novel therapeutic approaches. At the same time, we are constantly improving established products. In this context, Bayer HealthCare Pharmaceuticals uses experience it has gained from over a century in healthcare.
Bayer’s heritage in pharmaceuticals goes back almost 125 years, with the first therapy manufactured in 1888. Bayer quickly developed a reputation, particularly in treating infectious diseases. Gerhard Domagk, a Bayer researcher, who discovered the antibacterial effect of sulfonamides was awarded the Nobel Prize in Medicine in 1939.
We concentrate on five big therapeutic groups in which we make essential contributions to medical progress:
- Cardiovascular and blood diseases
- Oncological diseases
- Ophthalmology
- Women's healthcare
- Imaging techniques

Overview
Bayer Healthcare

Bookmark this page
Advanced search


